Search Saint Luke's

Rehospitalization after aortic valve replacement (AVR) is associated with an increased risk of patient mortality, according to new research.

The study shows that the diabetes and weight loss drug semaglutide significantly reduced symptoms and improved quality of life in people with obesity and the most common form of heart failure in a clinical trial.

Survival rates for Black women are far worse after bystander CPR than for white men, according to a study published this month.

The popular weight loss drug Wegovy seems to provide more health benefits for people who have diabetes and a common kind of heart failure than just helping take off the pounds, according to the results from the STEP HFpEF DM trial.

The diabetes and weight loss drug semaglutide significantly reduced symptoms and improved quality of life in people with obesity and the most common form of heart failure in a clinical trial.

Dr. Mikhail Kosiborod presented on the benefits of a cardiometabolic center of excellence for patients with cardiometabolic diseases at the ADA conference in San Diego.

Saint Luke’s Mid America Heart Institute was the first in Kansas and Missouri, and one of only 27 US institutions, to participate in PULSED AF clinical trial.

To combat rising maternal mortality, researchers at Saint Luke's Mid America Heart Institute and UMKC are leading a first of its kind study to create better care for moms with heart conditions during pregnancy.

FOX4 talked to Dr. Randall Thompson about the decade-long study of ancient mummies.

Dr. James O'Keefe, preventive cardiologist with Saint Luke's Mid America Heart Institute, joins FOX4 to talk about what it is, the pros and cons of intermittent fasting, and who would benefit from it most.